Franklin Resources Inc. Purchases 10,926 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Franklin Resources Inc. boosted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 0.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,311,166 shares of the company’s stock after purchasing an additional 10,926 shares during the period. Franklin Resources Inc.’s holdings in Privia Health Group were worth $25,633,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of PRVA. Riverbridge Partners LLC raised its holdings in shares of Privia Health Group by 19.7% in the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after buying an additional 958,418 shares during the period. Loomis Sayles & Co. L P increased its stake in Privia Health Group by 55.0% in the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company’s stock worth $27,727,000 after purchasing an additional 503,002 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Privia Health Group by 111.7% during the fourth quarter. JPMorgan Chase & Co. now owns 398,738 shares of the company’s stock worth $7,795,000 after purchasing an additional 210,354 shares during the last quarter. Barclays PLC boosted its stake in shares of Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after purchasing an additional 158,188 shares during the period. Finally, Sei Investments Co. grew its holdings in shares of Privia Health Group by 26.2% in the fourth quarter. Sei Investments Co. now owns 573,635 shares of the company’s stock worth $11,215,000 after purchasing an additional 119,052 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Insider Buying and Selling at Privia Health Group

In other news, CFO David Mountcastle sold 5,630 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total transaction of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares in the company, valued at approximately $4,021,148.88. This represents a 3.04 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 14.20% of the stock is owned by insiders.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $21.97 on Monday. The stock has a market capitalization of $2.65 billion, a P/E ratio of 219.72, a P/E/G ratio of 3.47 and a beta of 0.88. The company’s 50-day simple moving average is $23.78 and its 200-day simple moving average is $21.32. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $26.04.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on PRVA shares. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a report on Friday, February 28th. Macquarie initiated coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. Canaccord Genuity Group increased their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 target price on shares of Privia Health Group in a research report on Friday, March 21st. Finally, Stephens reiterated an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Privia Health Group currently has a consensus rating of “Buy” and a consensus target price of $26.67.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.